Michael Kelly
Direktor/Vorstandsmitglied bei PRIME MEDICINE, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Michael Kelly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEOGENOMICS, INC. | Direktor/Vorstandsmitglied | 15.07.2020 | - |
Independent Dir/Board Member | 15.07.2020 | - | |
DMC GLOBAL INC. | Direktor/Vorstandsmitglied | 24.07.2020 | - |
Independent Dir/Board Member | 24.07.2020 | - | |
AMICUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
Independent Dir/Board Member | 01.12.2020 | - | |
PRIME MEDICINE, INC. | Direktor/Vorstandsmitglied | 01.11.2021 | - |
Independent Dir/Board Member | 01.11.2021 | - | |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Direktor/Vorstandsmitglied | 01.07.2020 | - |
Sentry Hill Partners LLC | Gründer | 01.01.2018 | - |
Präsident | 01.01.2018 | - | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | 15.02.2019 | - |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | 27.09.2023 | - |
Karriereverlauf von Michael Kelly
Ehemalige bekannte Positionen von Michael Kelly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HOOKIPA PHARMA INC. | Direktor/Vorstandsmitglied | 01.02.2019 | 07.04.2023 |
Independent Dir/Board Member | 01.02.2019 | 07.04.2023 | |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Michael Kelly
Florida A&M University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 19 |
Österreich | 2 |
Operativ
Director/Board Member | 10 |
Director of Finance/CFO | 6 |
Independent Dir/Board Member | 6 |
Sektoral
Health Technology | 10 |
Health Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 8 |
---|---|
AMGEN INC. | Health Technology |
BIOGEN INC. | Health Technology |
HOOKIPA PHARMA INC. | Health Technology |
NEOGENOMICS, INC. | Health Services |
DMC GLOBAL INC. | Industrial Services |
APREA THERAPEUTICS, INC. | Health Technology |
AMICUS THERAPEUTICS, INC. | Health Technology |
PRIME MEDICINE, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Onyx Capital Management LLC
Onyx Capital Management LLC Investment ManagersFinance Onyx Capital Management LLC is a New York City-based hedge fund firm. | Finance |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
The NutraSweet Co.
The NutraSweet Co. Agricultural Commodities/MillingProcess Industries The NutraSweet Co. manufactures and distributes sweetener products. The company was founded in 1965 and is headquartered in Chicago, IL | Process Industries |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
Direct Relief
Direct Relief Miscellaneous Commercial ServicesCommercial Services Direct Relief provides medical assistance to improve the quality of life for people affected by poverty, disaster, and civil unrest at home and throughout the world. Direct Relief works to support the work of healthcare providers, equipping them with the medicines, supplies and equipment. The company is headquartered in Santa Barbara, CA. | Commercial Services |
Sentry Hill Partners LLC | |
Monsanto Life Sciences Co. | |
Nutrasweet Kelco Co. Ltd. | |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
- Börse
- Insiders
- Michael Kelly
- Erfahrung